Ethos Collaborates with Liberty Mutual to Deliver a Modern, Digital-First Life Insurance Experience
April 23, 2026
Biotechnology
-
-
CytoDyn Presents New Leronlimab Data in Metastatic Colorectal Cancer at AACR Annual Meeting 2026
April 22, 2026
-
NextCure and Simcere’s SIM0505 (CDH6 ADC) Phase 1 Data to be Presented at ASCO 2026
April 21, 2026
-
Vaxart Announces Share Purchase Agreement for up to $25 Million with Lincoln Park Capital
April 17, 2026
-
Oncotelic Therapeutics Reports FY 2025 Results Highlighting $249M Net Income and JV Pipeline Progress
April 16, 2026
-
Intensity Therapeutics Recognized with Pinnacle Award for Excellence in Healthcare Innovation
April 15, 2026
-
Obsidian Therapeutics and Galera Therapeutics Announce Merger Agreement and $350 Million Concurrent Private Placement
April 14, 2026
-
PharmaTher Announces Filing of U.S. Patent Application for its Peptide Microneedle Patch Technology
April 13, 2026
-
The Radoff-JEC Group Submits Non-Binding Proposal to Acquire Seer, Inc.
April 13, 2026
-
BiomX Accelerates Defense Technology Buildout with DFSL Acquisition
April 13, 2026
-
Oncotelic Therapeutics Inc. (OTCQB: OTLC) Strengthening Position with AI-Driven Tech in Automated Compliance Space
April 10, 2026
-
Annovis Closes $10 Million Offering, Extending Cash Runway Through Phase 3 Alzheimer’s Disease 6-Month NDA Submission
April 10, 2026
-
BiomX Acquires Zorronet, Autonomous AI Command-and-Control Platform for Real-Time Defense and Security Applications
April 10, 2026
-
Annovis Announces $10 Million Underwritten Offering of Common Stock and Accompanying Warrants
April 9, 2026
-
Onconetix Highlights Realbotix’s Launch of Vinci AI Vision System with Delivery of First Vinci-Equipped Humanoid Robot to Ericsson
April 9, 2026
-
Biofrontera Inc.: A Dermatology Company Scaling with Momentum
April 8, 2026